GLP-1 agonists—so-called “wonder drugs” like Ozempic or Wegovy that help individuals lower blood sugar levels and lose weight, among other things—yield significant results for some patients, but not all. People’s motivations to overeat may play a role in this, according to a new study. To investigate why some people don’t benefit from GLP-1 agonists as […]
Ozempic Is an ‘Essential’ Drug, WHO Says as Agency Calls for Cheaper Generics
One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of essential medicines. The WHO’s Model Lists of Essential Medicines is designed to improve affordability and access for the world’s most impactful drugs. Semaglutide and other […]
A Pill to Fight Obesity Is on the Verge of Approval
The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental oral GLP-1 drug, orforglipron. On Tuesday morning, Eli Lilly reported that orforglipron met the benchmarks of the company’s Phase III ATTAIN-2 study. People taking orforglipron […]
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government may not have closed the window on paying for GLP-1 weight loss drugs like Ozempic and Zepbound after all. The Trump administration is reportedly planning to conduct an experiment that will allow some people to have obesity drugs covered by their Medicaid and Medicare plans. The Washington Post first broke the news […]
This Experimental Weight Loss Drug Works Without the Nausea or Vomiting
What if you could lose weight with a drug that won’t make you lose your lunch at the same time? New research shows it might be possible. Scientists at the University of Pennsylvania, the University of Kentucky, and other institutions say they’ve found a potentially novel way to suppress people’s appetite and treat obesity—without causing […]
This Simple Strategy Could Curb One of Semaglutide’s Worst Side Effects
Semaglutide’s ability to help people lose weight is legendary, but so are the side effects. The active ingredient in medications Wegovy and Ozempic, semaglutide is renowned for causing severe nausea in some people, sometimes to the extent that they stop treatment. But new research published in the journal Diabetes Care suggests there may be a […]
Need a Testosterone Boost? Maybe Try Some Ozempic
Is there anything that Ozempic and drugs like it can’t do? A study out today finds that GLP-1 medications often raise men’s testosterone. Scientists in St. Louis, Missouri, led the research, which studied men taking one of several GLP-1 drugs for their type 2 diabetes or obesity. On average, men’s testosterone rose significantly after they started […]
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs
Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution […]
The Ugly Side of Weight-Loss Drugs: Rotten Breath, Damaged Teeth, and Dry Mouth
Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss. But as the drug has become more widely used, a number of unintended side-effects have become apparent—with the weight loss drug affecting the appearance of everything from your butt to your feet. “Ozempic face” is another commonly reported consequences of […]
Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that, amidst a recent downturn in the company’s stock, Lars Fruergaard Jørgensen would soon be stepping down as its top executive and the board would […]